Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
There isn’t a day that goes by where I don’t read a comment about cancer-related fatigue in myeloma. A myeloma patient is struggling with this side effect of chemotherapy to manage their incurable blood cancer. Myeloma patients desperate for help managing side effects from their treatment.
Sadly, the most frequently offered solutions are moderate exercise, coffee or even ritalin. No, a good night’s sleep does not help cancer-related fatigue in myeloma.
Interestingly, the content linked below offers traditional chinese medicine called Bushen-Jianpi decoction.
What are the health benefits of Bushen-Jianpi decoction?
While scientific research is ongoing, some studies and traditional uses suggest potential health benefits:
The specific composition can vary, but it typically includes herbs such as:
When I was told that I was end-stage after 3.5 years of surgery, chemo and radiation, I decided to try other forms of medicine.
The shops in the video above look like the shop I went to in the Chinatown here in Cleveland, Ohio. I don’t know if you have a Chinatown were you live but good luck in finding the herbs listed below.
Email me a David.PeopleBeatingCancer@gmail.com if you have questions about multiple myeloma
Good luck,
David Emerson
“The Jianpi therapeutic strategy in traditional Chinese medicine aims to enhance the spleen’s digestive function and overall wellness. It has shown promise in improving cancer-related fatigue (CRF).
This research systematically evaluates the effectiveness of Jianpi therapy in reducing fatigue in cancer patients through a meta-analytic review.
Methods: An exhaustive search was performed within PubMed, Embase, Web of Science, Cochrane Library, SinoMed, Wanfang Data, China Science and Technology Journal Database, and China National Knowledge Infrastructure (CNKI) for randomized controlled trials concerning the application of Jianpi therapy to address CRF…
The Cochrane Risk of Bias Assessment Tool 2.0 was utilized to assess the potential biases within the studies.A comprehensive analysis was performed on 45 eligible studies, all of which were conducted within China and encompassed a total of 3,596 participants.
The meta-analysis indicated that Jianpi decoction alone exhibited the most significant improvement in the proportion of CD4 cells (SMD=1.34, 95% CI 0.54 to 2.31, P<0.001) and hemoglobin (MD=7.45, 95% CI 4.18 to 10.72, Z=4.47, P<0.001), while also more significantly reducing Piper Fatigue Scale scores (SMD=-2.05, 95% CI -2.71 to -1.39, P<0.001).
The combined therapy, which integrated Jianpi therapy with standard care, demonstrated the greatest advantage in enhancing the proportion of CD3 cells (SMD=1.25, 95% CI 0.46 to 2.04, P<0.001).
Furthermore, Jianpi therapy was found to be effective in lowering tumor necrosis factor-alpha levels P<0.001) and concurrently enhancing interferon-gamma (MD=5.15, 95% CI 3.20 to 7.09, P=0.002), interleukin-2 (MD=8.37, 95% CI 6.14 to 10.59, P<0.001).
Our research indicates that Jianpi therapy effectively alleviates CRF, reduces inflammation, and strengthens immune function. However, further high-quality, multicenter randomized controlled trials are essential to confirm these findings and strengthen the evidence.”
cancer-related fatigue in myeloma cancer-related fatigue in myeloma